Loading…
avatar for Brian Albarran, PhD, MBA

Brian Albarran, PhD, MBA

Kymera
Senior Vice President, Corporate Strategy
As Senior Vice President, Head of Corporate Strategy at Kymera Therapeutics, Brian is responsible for the development and coordination of strategic initiatives that drive value creation and corporate growth. Brian joined Kymera from TESARO (now a GSK Company) where, as a Program Team Leader, he oversaw the FDA approval of the NK1RA rolapitant/Varubi IV and led multiple clinical programs in immuno-oncology, including the anti-PD-1 dostarlimab/Jemperli. While at TESARO, Brian also built and led the Competitive Intelligence function to support both clinical and commercial oncology programs, including the PARP inhibitor niraparib/Zejula. Brian was previously a strategy consultant at Leerink and Navigant Consulting after numerous biotech roles in process development, manufacturing, and business development at ICOS, Trubion Pharmaceuticals, and Emergent BioSolutions. Brian earned his MBA from the Wharton School of Business and holds a PhD in Bioengineering from the University of Washington and a BSE in Biomedical Engineering from Duke University.